Your browser doesn't support javascript.
loading
Monotherapy Administration of Sorafenib in Patients With Non-Small Cell Lung Cancer (MISSION) Trial: A Phase III, Multicenter, Placebo-Controlled Trial of Sorafenib in Patients with Relapsed or Refractory Predominantly Nonsquamous Non-Small-Cell Lung Cancer after 2 or 3 Previous Treatment Regimens.
Paz-Ares, Luis; Hirsh, Vera; Zhang, Li; de Marinis, Filippo; Yang, James Chih-Hsin; Wakelee, Heather A; Seto, Takashi; Wu, Yi-Long; Novello, Silvia; Juhász, Erszébet; Arén, Osvaldo; Sun, Yan; Schmelter, Thomas; Ong, Teng Jin; Peña, Carol; Smit, Egbert F; Mok, Tony S.
Affiliation
  • Paz-Ares L; Instituto de Investigaciones Biomédicas de Sevilla, Hospital Universitario Virgen del Rocío/Universidad de Sevilla/CSIC, Seville, Spain. Electronic address: lpazaresr@seom.org.
  • Hirsh V; Department of Oncology, McGill University Health Centre, Montreal, QC, Canada.
  • Zhang L; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
  • de Marinis F; Pulmonary Oncological First Unit, Azienda Ospedaliera S. Camillo Forlanini, Rome, Italy.
  • Yang JC; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
  • Wakelee HA; Department of Medicine, Division of Oncology, Stanford University Cancer Center, Stanford, California.
  • Seto T; Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan.
  • Wu YL; Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Novello S; Department of Clinical & Biological Sciences, University of Turin, Turin, Italy.
  • Juhász E; Department of Pulmonology XIV, Koranyi National Institute of TB and Pulmonology I and XIV, Budapest, Hungary.
  • Arén O; Unidad de Oncologia Tocacica, International Center of Clinical Studies, Santiago, Chile.
  • Sun Y; Cancer Hospital/Institute, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
  • Schmelter T; Bayer Pharma AG, Berlin, Germany.
  • Ong TJ; Bayer HealthCare Pharmaceuticals, Whippany, New Jersey.
  • Peña C; Bayer HealthCare Pharmaceuticals, Whippany, New Jersey.
  • Smit EF; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Mok TS; Department of Clinical Oncology, Chinese University of Hong Kong, Hong Kong, China.
J Thorac Oncol ; 10(12): 1745-53, 2015 Dec.
Article in En | MEDLINE | ID: mdl-26743856
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Niacinamide / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Antineoplastic Agents Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Journal: J Thorac Oncol Year: 2015 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Niacinamide / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Antineoplastic Agents Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Journal: J Thorac Oncol Year: 2015 Document type: Article